Oral News and Research

RSS

Decibel obtains exclusive license to commercialize ORC-13661 for preventing hearing, balance disorders

Decibel Therapeutics and Oricula Therapeutics today announced that Decibel has obtained an exclusive, worldwide license to the development and commercialization of ORC-13661, an oral medication developed by Oricula Therapeutics for the prevention of hearing loss and balance disorders that can occur following treatment of severe infections with aminoglycoside antibiotics.

27 Sep 2018

No scientific reason available to assume link between BPA uptake and MIH in children

Depending on symptomatic and phenotypic severity the condition of chalky teeth is categorised into three levels. The symptoms of chalky teeth were first described in 1978, with the term molar-incisor hypomineralisation introduced in 2001.

27 Sep 2018

Research findings could bring relief to millions of cancer patients undergoing chemotherapy

Patients undergoing cancer treatment confront a number of well-documented side effects.

26 Sep 2018

Researchers develop promising allergy vaccine for hay fever

Using sugar molecules researchers from the University of Copenhagen have developed a new vaccine for hay fever that may reduce treatment times and increase the effect of treatments.

26 Sep 2018

Antibiotics actually kill 'good' bacteria and worsen oral infection, finds study

New research shows that the body's own microbes are effective in maintaining immune cells and killing certain oral infections.

26 Sep 2018

Cerevance starts dosing in Phase I clinical trial of CVN424 for treatment of Parkinson's disease

Cerevance, a clinical-stage drug discovery and development company focused on brain diseases, today announced the start of dosing in a Phase I first-in-human clinical trial of CVN424, an oral compound being developed for symptomatic treatment of Parkinson's disease.

25 Sep 2018

Recurrence risk of VTE appears similar for patients with cancer and those with unprovoked VTE

Patients with venous thromboembolism carry a high risk of recurrence. Accordingly, a 16-year Danish prospective cohort study of nearly 74,000 patients with incident VTE concluded that the risk of recurrence is substantial.

25 Sep 2018

Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone

Lumos Pharma, Inc., a clinical stage biopharmaceutical company focused on development and commercialization of therapeutics for rare and neglected diseases, today announced that it has acquired the license for LUM-201, an investigational orally administered small molecule that promotes secretion of growth hormone from the pituitary gland, from Ammonett Pharma LLC.

24 Sep 2018

FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial

AstraZeneca today announced positive results from the Phase III DECLARE-TIMI 58 cardiovascular outcomes trial for FARXIGA, the broadest SGLT-2 inhibitor CVOT conducted to date.

24 Sep 2018

‘Physicians of the mouth’? Dentists absorb the medical billing drill

On a recent Friday morning, more than 30 dentists and dental staffers gathered in a conference room to learn an arcane new skill: how to bill medical insurers.

24 Sep 2018

BetterYou receives double accolade at Janey Loves Platinum Awards 2018

Pioneering natural health company BetterYou has received two awards at the annual Janey Loves Platinum Awards 2018.

From BetterYou Ltd 24 Sep 2018

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.

24 Sep 2018

New study provides basis for Air Canada to change its facial hair policy for aircrew

A study conducted in Simon Fraser University's hypobaric chamber has sealed Air Canada's decision to allow pilots to sport facial hair.

24 Sep 2018

New findings on characteristics of Burning Mouth Syndrome

The picture is becoming clearer regarding the chronic oral pain condition known as Burning Mouth Syndrome, or BMS, which mainly affects women who are middle-aged and older. In a dissertation at Sahlgrenska Academy, additional steps are being taken toward better diagnosis and treatment.

21 Sep 2018

EFS checklist provides user-friendly tool for evaluating feeding skills in preterm infants

Infants born prematurely face challenges in developing the complex, interrelated skills needed for effective feeding.

21 Sep 2018

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

Ipsen announced today that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, provided a positive opinion for Cabometyx (cabozantinib) as a monotherapy for the treatment of hepatocellular carcinoma in adults who have been previously treated with sorafenib.

21 Sep 2018

Top three immune boosting recommendations to ward off freshers’ flu

Those heading to university this autumn, or returning student’s, might’ve heard of the dreaded freshers’ flu. But don’t let it fool you, it isn’t actually a form of flu.

20 Sep 2018

Addition of CTLA4 targeted therapy to PD-1 targeted therapy may benefit patients with ovarian cancer

An analysis of the NRG Oncology clinical trial NRG-GY003 suggests that adding ipilimumab, a monoclonal antibody that targets the protein receptor CTLA-4, to a regimen with the checkpoint inhibitor nivolumab could improve the proportion with tumor response and progression-free survival hazard rates for women with recurrent epithelial ovarian cancer.

19 Sep 2018

Leading nutritionist explains about different types of iron in oral supplements

Iron is the top nutritional deficiency in the world, as many as 80 percent of people do not have enough iron in their body according to the World Health Organization.

From BetterYou Ltd 19 Sep 2018

Young children's oral microbiota could serve as early indicator for obesity

Weight gain trajectories in early childhood are related to the composition of oral bacteria of two-year-old children, suggesting that this understudied aspect of a child's microbiota -- the collection of microorganisms, including beneficial bacteria, residing in the mouth -- could serve as an early indicator for childhood obesity.

19 Sep 2018

Oral News and Research

Decibel obtains exclusive license to commercialize ORC-13661 for preventing hearing, balance disorders

No scientific reason available to assume link between BPA uptake and MIH in children

Research findings could bring relief to millions of cancer patients undergoing chemotherapy

Researchers develop promising allergy vaccine for hay fever

Antibiotics actually kill 'good' bacteria and worsen oral infection, finds study

Cerevance starts dosing in Phase I clinical trial of CVN424 for treatment of Parkinson's disease

Recurrence risk of VTE appears similar for patients with cancer and those with unprovoked VTE

Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone

FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial

‘Physicians of the mouth’? Dentists absorb the medical billing drill

BetterYou receives double accolade at Janey Loves Platinum Awards 2018

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

New study provides basis for Air Canada to change its facial hair policy for aircrew

New findings on characteristics of Burning Mouth Syndrome

EFS checklist provides user-friendly tool for evaluating feeding skills in preterm infants

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

Top three immune boosting recommendations to ward off freshers’ flu

Addition of CTLA4 targeted therapy to PD-1 targeted therapy may benefit patients with ovarian cancer

Leading nutritionist explains about different types of iron in oral supplements

Young children's oral microbiota could serve as early indicator for obesity

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News